PureCycle Technologies (PCT) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
27 Mar, 2026Executive summary
The annual meeting is scheduled for May 7, 2026, with shareholders voting on director elections, auditor ratification, and executive compensation approval.
Record 22.4MM pounds of resin produced in 2025, with four consecutive quarters of revenue growth.
Expansion includes a new facility in Thailand and a €40MM EU grant for a Belgian facility.
Received GreenCircle and APR certifications, and EU REACH compliance.
Forward-looking statements highlight ongoing risks and uncertainties, with management retaining flexibility to adjust plans.
Voting matters and shareholder proposals
Shareholders will elect nine directors, ratify Grant Thornton LLP as auditor for 2026, and approve executive compensation on an advisory basis.
Board recommends voting FOR all proposals.
Shareholder proposals for 2027 must be submitted by November 27, 2026, with specific nomination and universal proxy rules outlined.
Board of directors and corporate governance
Nine director nominees, including two new appointees, with diverse backgrounds in chemicals, finance, and sustainability.
Board committees: Audit & Finance, Compensation, Nominating & Corporate Governance, and Operational Excellence.
Leadership structure separates Chairman and CEO roles, with a Lead Independent Director providing additional oversight.
Governance framework includes a Code of Conduct, insider trading policy, and annual board/committee evaluations.
Stock ownership guidelines require directors to hold 4x their annual base cash retainer.
Latest events from PureCycle Technologies
- Record production, new funding, and strong trials set stage for growth despite ongoing losses.PCT
Q3 20249 Jul 2026 - Operational and commercial milestones, funding, and strong demand drive growth outlook.PCT
Q4 20248 Jul 2026 - First $1.6M revenue, 90% uptime, BOPP breakthroughs, and $59M+ capital raised in Q1 2025.PCT
Q1 20258 Jul 2026 - Record production and revenue growth, with robust liquidity and strong commercial momentum.PCT
Q1 20267 May 2026 - Virtual meeting to elect nine directors, ratify auditor, and approve executive pay.PCT
Proxy filing27 Mar 2026 - Proposal seeks to lower the warrant Redemption Trigger Price and extend expiration to 2027.PCT
Proxy filing26 Mar 2026 - Gen 2 technology and regulatory shifts position the company for rapid growth and global expansion.PCT
The 38th Annual Roth Conference23 Mar 2026 - Proposal seeks to lower warrant trigger price and extend expiration, pending majority consent.PCT
Proxy Filing16 Mar 2026 - Record Q4 production and $2.7M revenue growth set the stage for global expansion in 2026.PCT
Q4 202527 Feb 2026